Target intelligence / Profile preview

Long intergenic non-protein coding RNA 1696 (LINC01696)

Target
LINC01696
Molecular classification
Long intergenic non-coding RNA (lincRNA), Long non-coding RNA (lncRNA) family, Other
01

Overview

Long intergenic non-protein coding RNA 1696 (LINC01696) is classified as a long intergenic non-coding RNA (lincRNA), a subclass of long non-coding RNAs that are longer than 200 nucleotides and do not overlap with annotated protein-coding genes. LINC01696, like other lincRNAs, is transcribed but not translated into protein. LincRNAs are known to play roles in regulating the expression of neighboring genes with high tissue specificity, utilizing a variety of mechanisms including chromatin remodeling, modification of nuclear architecture, transcriptional regulation, and possibly enhancer-like functions. Only a small subset of lincRNAs have been functionally characterized, and while dysregulation of certain lincRNAs is implicated in human disease and cancer, there are currently no known interactions, biomarker uses, or therapeutic agents targeting LINC01696 specifically.

Other names
LINC01696
02

Mechanism of action

None known or documented for drugs, as LINC01696 is not an established therapeutic target.

03

Biological functions

Regulation of gene expression (transcriptional and post-transcriptional)Chromatin remodelingModulation of genome architecturePotential enhancer-associated (regulatory) activityRNA stabilizationOther
04

Disease associations

No disease roles specifically documented for LINC01696 as of now; however, lincRNAs as a class have been functionally linked to: Cancer (for other family members, e.g., XIST, HOTAIR)Other (potentially, but not directly documented for LINC01696)
05

Safety considerations

None specific to LINC01696 are documented.
06

Interacting drugs

None known or documented for LINC01696.
07

Biomarkers

None established for LINC01696; lincRNAs in general may serve as biomarkers for certain diseases

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 1696 (LINC01696).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 1696 (LINC01696).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call